Mónica
Marazuela Azpiroz
Publicacións nas que colabora con Mónica Marazuela Azpiroz (35)
2024
-
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-related cancer
-
Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466
-
Glucose metabolism outcomes after pituitary surgery in patients with acromegaly
Pituitary
-
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study
European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433
-
Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Endocrine-Related Cancer, Vol. 31, Núm. 7
2023
-
Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
Frontiers in Endocrinology, Vol. 14
2022
-
Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study
Endocrine, Vol. 75, Núm. 2, pp. 525-536
-
Data mining analyses for precision medicine in acromegaly: a proof of concept
Scientific Reports, Vol. 12, Núm. 1
-
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
Biomedicines, Vol. 10, Núm. 2
2021
-
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas
Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819
-
Pasireotide in the Personalized Treatment of Acromegaly
Frontiers in Endocrinology, Vol. 12
2020
-
Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly
Endocrine, Vol. 70, Núm. 3, pp. 575-583
-
Molecular profiling for acromegaly treatment: a validation study
Endocrine-related cancer, Vol. 27, Núm. 6, pp. 375-389
2018
-
Expert document on management of acromegaly
Endocrinologia, Diabetes y Nutricion, Vol. 65, Núm. 8, pp. 428-437
2016
-
El Registro Molecular de Adenomas Hipofisarios (REMAH): una apuesta de futuro de la Endocrinología española por la medicina individualizada y la investigación traslacional
Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 63, Núm. 6, pp. 274-284
-
Genetic Predictors of Response to Different Medical Therapies in Acromegaly
Progress in Molecular Biology and Translational Science (Elsevier B.V.), pp. 85-114
-
Long-term treatment with pegvisomant for acromegaly: A 10-year experience
Clinical Endocrinology, Vol. 84, Núm. 4, pp. 540-550
-
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
Pituitary, Vol. 19, Núm. 2, pp. 127-137
-
Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study
Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 63, Núm. 8, pp. 397-408
2015
-
Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: Association with clinical presentation and response to treatments
European Journal of Endocrinology, Vol. 172, Núm. 2, pp. 115-122